<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Nephrol</journal-id>
      <journal-title>BMC Nephrology</journal-title>
      <issn pub-type="epub">1471-2369</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17490479</article-id>
      <article-id pub-id-type="pmc">1885430</article-id>
      <article-id pub-id-type="publisher-id">1471-2369-8-7</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2369-8-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Javaid</surname>
            <given-names>Muhammad M</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mmjaved68@hotmail.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Denley</surname>
            <given-names>Helen</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>Helen.Denley@CMMC.nhs.uk</email>
        </contrib>
        <contrib id="A3" corresp="yes" contrib-type="author">
          <name>
            <surname>Tagboto</surname>
            <given-names>Senyo</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>senyo.tagboto@uhns.nhs.uk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Glan Clwyd Hospital, Bodelwyddan, Rhyl, LL18 5UJ, UK</aff>
      <aff id="I2"><label>2</label>Department of Histopathology, 1st Floor, Clinical Sciences Building 1, Central Manchester and Manchester Childrens University Hospitals NHS Trust, Oxford Road, Manchester, M13 9WL, UK</aff>
      <aff id="I3"><label>3</label>University Hospital of North Staffordshire, Royal Infirmary, Princes Road, Hartshill, Stoke-on-Trent, ST4 7LN, UK</aff>
      <pub-date pub-type="collection">
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>5</month>
        <year>2007</year>
      </pub-date>
      <volume>8</volume>
      <fpage>7</fpage>
      <lpage>7</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2369/8/7"/>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>6</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2007 Javaid et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2007</copyright-year>
        <copyright-holder>Javaid et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Javaid
               M
               Muhammad
               
               mmjaved68@hotmail.com
            </dc:author><dc:title>
            Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
         </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Nephrology 8(1): 7-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2369(2007)8:1&#x0003c;7&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2369</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Fibrillary glomerulonephritis is a rare cause of progressive renal dysfunction, often leading to the need for dialysis within a few years. The role of immunosuppressive treatment is still uncertain although this has been tried with variable success.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 56 year old woman with the antiphospholipid antibody syndrome (IgM anticardiolipin antibodies) was seen in the nephrology clinic with haematuria, proteinuria, and worsening renal function. A renal biopsy demonstrated a mesangial proliferative glomerulonephritis on light microscopy and smaller fibrils (10.6&#x2013;13.8 nm in diameter) than is usual for fibrillary glomerulonephritis (typically 18&#x2013;22 nm) on electron microscopy. Amyloidosis was excluded following detailed evaluation. On account of rapidly worsening renal failure she was started on cyclophosphamide and prednisolone which led to the partial recovery and stabilization of her renal function.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This case highlights the need for routine electron microscopy in native renal biopsies, where the differential diagnosis is wide and varied and the light and immunofluorescence microscopic findings may be non specific.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Fibrillary glomerulonephritis (FibGN) is a rare cause of progressive renal dysfunction. The majority of patients who develop the disease require dialysis within a few years [<xref ref-type="bibr" rid="B1">1</xref>]. It was first described by Rosenmann and Eliakim in 1977 as an amyloid-like glomerulopathy but with negative congo red staining [<xref ref-type="bibr" rid="B2">2</xref>]. Alpers <italic>et al </italic>introduced the term FibGN in 1987 [<xref ref-type="bibr" rid="B3">3</xref>]. It is characterized by the deposition of randomly arranged fibrils in the mesangium and glomerular basement membrane. The fibrils are generally less than 30 nm in diameter, with the majority measuring approximately 20 nm. This condition is closely related to immunotactoid glomerulopathy (see table <xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. There is some overlap between these two conditions, which has led some pathologists to propose that they should be classified together as one entity [<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Classification and clinical features of fibrillary and immunotactoid glomerulopathies</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td/>
              <td align="left">
                <bold>Fibrillary glomerulonephritis</bold>
              </td>
              <td align="left">
                <bold>Immunotactoid glomerulopathy</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Composition</td>
              <td align="left">Fibrils</td>
              <td align="left">Microtubules</td>
            </tr>
            <tr>
              <td align="left">Fibril or microtubule size</td>
              <td align="left">Average diameter 18&#x2013;22 nm (usual range 12&#x2013;30 nm)</td>
              <td align="left">Typically &gt;30 nm (range 16&#x2013;90 nm)</td>
            </tr>
            <tr>
              <td align="left">Arrangement of fibrils or microtubules</td>
              <td align="left">Randomly arranged fibrils</td>
              <td align="left">Parallel arrays of microtubules</td>
            </tr>
            <tr>
              <td align="left">Immunoglobulin type</td>
              <td align="left">Usually polyclonal (mostly IgG4 sometimes with IGg1) occasionally monoclonal (IgG&#x3BA;)</td>
              <td align="left">Usually monoclonal IgG&#x3BA; or IgG&#x3BB;</td>
            </tr>
            <tr>
              <td align="left">Light microscopy</td>
              <td align="left">Mesangial proliferation, membranoproliferative GN crescentic GN, sclerosing GN diffuse proliferative GN with endocapilliary exudation</td>
              <td align="left">Atypical membranous GN, diffuse proliferative GN membranoproliferative GN</td>
            </tr>
            <tr>
              <td align="left">Association with lymphoproliferative disorder</td>
              <td align="left">Uncommon</td>
              <td align="left">Common (chronic lymphocytic leukaemia, nonHodgkin lymphoma)</td>
            </tr>
            <tr>
              <td align="left">Renal presentation</td>
              <td align="left">Sub nephrotic or nephrotic range proteinuria + haematuria hypertension, rapidly progressive glomerulonephritis</td>
              <td align="left">Nephrotic syndrome with microhaematuria and hypertension</td>
            </tr>
            <tr>
              <td align="left">Other manifestations (fibrillar deposits)</td>
              <td align="left">Pulmonary haemorrhage</td>
              <td align="left">Microtubular inclusions in leukaemic lymphocytes</td>
            </tr>
            <tr>
              <td align="left">Treatment</td>
              <td align="left">Various immunosuppressive drugs tried with variable response (see table 1)</td>
              <td align="left">Treatment of the associated lymphoproliferative disorder</td>
            </tr>
            <tr>
              <td align="left">Racial predilection</td>
              <td align="left">Predominantly Caucasian</td>
              <td align="left">Predominantly Caucasian</td>
            </tr>
            <tr>
              <td align="left">Peak occurrence</td>
              <td align="left">5th to 6th decades</td>
              <td align="left">Age 60 years</td>
            </tr>
            <tr>
              <td align="left">Prognosis</td>
              <td align="left">Established renal failure in half of patients within 2&#x2013;4 years</td>
              <td align="left">Probably better renal prognosis than fibrillary GN</td>
            </tr>
            <tr>
              <td align="left">Frequency in renal biopsies</td>
              <td align="left">Approximately 1 % of renal biopsies</td>
              <td align="left">0.06% of renal biopsies</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Light microscopy typically demonstrates a mesangioproliferative or a membranoproliferative glomerulonephritis. Glomerular crescents are present in about 25% of biopsies [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Immunofluorescence may demonstrate IgG and C3, IgG4 being the predominant IgG subtype [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. IgA, IgM and C1q deposition are less commonly found.</p>
      <p>We report a case of FibGN in a 56 year old woman. The size of her fibrils were rather small ranging between 10.6&#x2013;13.8 nm. Further detailed evaluation did not demonstrate amyloid deposition. On account of rapidly worsening renal failure she was started on a trial of cyclophosphamide and prednisolone which led to the partial recovery and stabilization of her renal function.</p>
    </sec>
    <sec>
      <title>Case Presentation</title>
      <p>A 56 year old woman was referred to the nephrology outpatient clinic, in November 2004 with haematuria, proteinuria, and worsening renal function. Her only complaints were of intermittent macroscopic haematuria and right upper quadrant colicky abdominal pain.</p>
      <p>Her past medical history included hypertension, hyperlipidaemia and psoriasis. Additionally, she had an appendicectomy aged 16 and a cholecystectomy in 1984. She had been diagnosed with the antiphospholipid antibody syndrome (IgM anticardiolipin antibodies) following an episode of branch retinal artery thrombosis in September 2003, and a transient ischaemic attack in January 2004.</p>
      <p>Her medications included warfarin, atorvastatin and perindopril, although the latter had just been stopped by her General Practitioner.</p>
      <p>At the time of her initial review in the renal out-patient clinic, her blood pressure was 164/90 mmHg. Her urine dipstick contained blood (+++) and protein quantified at 0.52 g in 24 hours. Serum albumin levels were low at 31 g/l. An ultrasound scan demonstrated normal kidneys with a small benign cyst on her left kidney. An IVU and cystoscopy were reported as normal. Her serum creatinine levels measured 84 &#x3BC;mol/l in July 2003, 150 &#x3BC;mol/l in November 2004, and 300 &#x3BC;mol/l in January 2005. Further investigations showed a haemoglobin level of 8 g/dl. Serum Folate levels were normal; however, B12 and Ferritin levels were low at 171 pg/ml and 33.7 ng/ml respectively. Gastric parietal cell antibodies and intrinsic factor antibodies were not detected.</p>
      <p>ANA, ENA, ANCA and dsDNA antibodies, rheumatoid factor and cryoglobylins were not demonstrated. Serum angiotensin converting enzyme (ACE) levels and complement (C3 &amp; C4) were within normal limits.</p>
      <p>Serology for Hepatitis B and C was negative. C reactive protein levels were measured at 4 mg/l. Her ESR and plasma viscosity were elevated at 76 mm/hr and 1.98 mPas respectively. Serum electrophoresis revealed no abnormalities, and Bence-Jones proteins were not detected in a urine specimen.</p>
      <p>Light microscopy showed nine glomeruli, two of which were globally sclerosed. Of the remainder, many showed a mesangial matrix increase with hypercellularity, without the evidence of necrotizing lesions or fibrin thrombi (fig. <xref ref-type="fig" rid="F1">1</xref>). Silver stain showed basement membrane wrinkling, but no evidence of spikes or double contours. In a single glomerulus on one level, there was prominence of the epithelial cells of Bowman's capsule, possibly with some associated fibrin possibly representing an early crescent (fig. <xref ref-type="fig" rid="F2">2</xref>). Established crescents were not seen. There was a moderate and patchy interstitial inflammatory infiltrate. There was no interstitial fibrosis or evidence of tubular atrophy. Some tubules contained red cells (fig. <xref ref-type="fig" rid="F3">3</xref>). The arteries showed focal thickening of their walls. Immunofluorescence showed diffuse patchy granular mesangial and peripheral IgG (2+), C3 (+), and IgM (+) (fig <xref ref-type="fig" rid="F4">4</xref>). IgA and C1q were negative. The appearance was essentially of a mesangial proliferative glomerulonephritis. Congo red stain was negative. Immunohistochemistry for AA, AL and A&#x3B2;2M amyloid were negative.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Electron micrograph or kidney biopsy demonstrating fibrils ranging in size from 10.6 to 13.8 nm (original magnification &#xD7; 64000).</p>
        </caption>
        <graphic xlink:href="1471-2369-8-7-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Kidney biopsy showing possible early crescent (haematoxylin and eosin stain, original magnification &#xD7; 100).</p>
        </caption>
        <graphic xlink:href="1471-2369-8-7-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Kidney biopsy showing mesangial proliferative changes (haematoxylin and eosin stain, original magnification &#xD7;100).</p>
        </caption>
        <graphic xlink:href="1471-2369-8-7-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Red cells and red cell cast in tubules (Masson trichrome stain, original magnification &#xD7;100).</p>
        </caption>
        <graphic xlink:href="1471-2369-8-7-4"/>
      </fig>
      <p>Electron microscopy of a single glomerulus showed numerous fibrils with a diameter of 10.6&#x2013;13.8 nm and within an expanded mesangial matrix. These findings suggested the diagnosis of FibGN although the small fibre size was somewhat suggestive of amyloid (FibGN typically has larger fibers, average diameter 20 nm).</p>
      <p>She was referred to the National Amyloidosis Centre who also assessed her renal biopsy and did not find evidence of amyloid. They assessed her serum free light chains, demonstrating slightly increased kappa levels at 29.3 mg/l and lambda levels at 39.7 mg/l, probably the consequence of the decreased renal clearance of normal light chains in this patient. However, the &#x3BA;/&#x3BB; ratio was normal at 0.74 (range 0.26&#x2013;1.65). Furthermore, serum amyloid P (SAP) scintigraphy did not reveal visceral amyloid deposition. A final diagnosis of FibGN was made.</p>
      <p>Once her serum creatinine levels reached 300 &#x3BC;mol/l in January 2005, she was started on Prednisolone (40 mg daily) and cyclophosphamide (100 mg daily). In addition she received intravenous iron therapy, B12 injections and erythropoietin beta. Her blood pressure was treated with perindopril and amlodipine.</p>
      <p>Following the initiation of immunosuppressive treatment, her serum creatinine levels improved to178 &#x3BC;mol/l in four weeks. Cyclophosphamide treatment was briefly withheld on two occasions in March and in May 2005 due to various minor infections, during which time her serum creatinine increased to 280 and 270 &#x3BC;mol/l respectively. Creatinine levels again improved on restarting immunosuppressive treatment to levels of approximately 200 &#x3BC;mol/l. Her renal function remained stable subsequently. Over the next year of follow, the dose of her cyclophosphamide was maintained while her prednisolone was slowly reduced to 5 mg daily. Following discontinuation of immunosuppressive treatment after a year, serum creatinine levels remained stable over the next 6 months of follow up (fig. <xref ref-type="fig" rid="F5">5</xref>).</p>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>Changes in estimated GFR (abbreviated MDRD formula) with time (see text for details).</p>
        </caption>
        <graphic xlink:href="1471-2369-8-7-5"/>
      </fig>
      <p>During the course of her illness, she had an episode of haematemisis and fresh bleeding per rectum. She also complained of easy skin bruising and had an episode of macroscopic haematuria. Upper gastrointestinal endoscopy and colonoscopy were normal. Unfortunately, a request, with the patient's permission to obtain biopsies at endoscopy to look for fibrils was inadvertently not carried out. A chest X-ray carried out to investigate a cough was reported as showing a bulky left hilum but a computed tomography scan of chest and upper abdomen was normal.</p>
      <p>FibGN occurs in approximately 1% of renal biopsies [[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B11">11</xref>] and [<xref ref-type="bibr" rid="B12">12</xref>]]. It is more common in Caucasians with a peak incidence between the fifth and the sixth decades of life [<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>Since the patient had been diagnosed with the antiphospholipid antibody syndrome, the presence of mesangioproliferative glomerulonephritis on light microscopy, initially suggested the diagnosis of lupus nephritis. However the presence of fibrils in the mesangium on electron microscopy and the negative staining for amyloid pointed to a diagnosis of FibGN, a condition with a relatively poor prognosis. It is quite possible that the diagnosis may be underreported where light microscopic findings are not routinely complemented by electron microscopy.</p>
      <p>The fibrils in our patient were 10.6&#x2013;13.8 nm in diameter. Fibrils of this size are possible in amyloidosis, which is characterized by the deposition of proteinaceous material in extracellular spaces, composed of a felt like array of 7.5&#x2013;10 nm wide, linear, non branching fibrils of indefinite length [<xref ref-type="bibr" rid="B13">13</xref>]. In our patient, congo red staining, immunohistochemistry and SAP scintigraphy did not reveal amyloid.</p>
      <p>Symptoms in FibGN are usually nonspecific and consist of proteinuria, haematuria, hypertension and renal insufficiency. Fibril deposition is predominantly confined to the kidneys. However, fibrillary deposits have been reported in the alveolar capillary membrane, producing a pulmonary-renal syndrome, and in the skin of a patient with leukocytoclastic skin vasculitis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Whether the episodes skin bruising, haematemesis, and rectal bleeding in our patient was due to fibrillary deposition in these organs or not is not known. Our patient was understandably not keen to be subjected to further biopsies to confirm the deposition of fibrils elsewhere.</p>
      <p>The pathogenesis of FibGN is not clearly understood at present. Immunofluorescence findings suggest an immunogenic origin. There in no definitive treatment for this condition. A few cases have been reported in the literature where immunosuppressive treatment has been used with varying success (see table <xref ref-type="table" rid="T2">2</xref>) [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. Half of all cases develop end stage renal failure within 4 years of diagnosis [<xref ref-type="bibr" rid="B31">31</xref>]. Although recurrence after renal transplantation has been described, the progression of renal dysfunction is often slow [<xref ref-type="bibr" rid="B31">31</xref>]. In our patient prednisolone and oral cyclophosphamide was started due to moderately rapidly deteriorating renal function. Renal function improved substantially within four weeks of initiating treatment and remained stable to date after more than a year of follow up. It is interesting to note that early in the course of her illness, treatment was briefly stopped on two occasions during which her serum creatinine levels increased.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Key publications regarding the efficacy of immunosuppressive drugs in treating fibrillary glomerulonephritis</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Treatment</bold>
              </td>
              <td align="left">
                <bold>Response</bold>
              </td>
              <td align="left">
                <bold>Authors</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Methyprednisolone/Prednisolone</td>
              <td align="left">No response</td>
              <td align="left">
                <italic>Asaba et al., 2003</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Mycophenolate mofetil</td>
              <td align="left">Persistent haematuria and proteinuria, improvement in serum creatinine levels</td>
              <td align="left">
                <italic>Bijol et al., 2006</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone, Cyclophosphamide then Cyclosporin</td>
              <td align="left">Brief initial response with prednisolone then relapse. No response with cyclophosphamide resolution of nephrotic syndrome with cyclosporin</td>
              <td align="left">
                <italic>Bircan et al., 2004</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Cyclophosphamide</td>
              <td align="left">Marked improvement in renal function</td>
              <td align="left">
                <italic>Blume et al., 2002</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Corticosteroids +/- Cyclophosphamide</td>
              <td align="left">No response in fibrillary glomerulonephritis.<break/>Variable response in immunotactoid glomerulopathy including melphalan, vincristine, doxorubicin, carmustine or chlorambucil in various combinations, remission or improvement in nephrotic syndrome in 10/12 patients, disappearance of deposits from the kidneys of 2 patients</td>
              <td align="left">
                <italic>Bridoux et al., 2002</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Cyclophosphamide then Azathioprine</td>
              <td align="left">Transient reduction in proteinuria</td>
              <td align="left">
                <italic>Chan han, 1998</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone</td>
              <td align="left">Resolution of nephrotic syndrome or reduction in proteinuria</td>
              <td align="left">
                <italic>Dickenmann et al., 2002</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Chlorambucil</td>
              <td align="left">Slight reduction in creatinine, reduction in proteinuria from 3 g to 1 g in 24 h.</td>
              <td align="left">
                <italic>Dussol et al., 1998</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone</td>
              <td align="left">No response</td>
              <td align="left">
                <italic>Gielen et al., 2006</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Cyclophosphamide then Azathioprine</td>
              <td align="left">No response</td>
              <td align="left">
                <italic>Hsu et al., 2001</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Cyclophosphamide</td>
              <td align="left">Recovery of renal function, discontinuation of dialysis</td>
              <td align="left">
                <italic>Mahajan et al., 2005</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone</td>
              <td align="left">Improvement in renal function, reduction in proteinuria</td>
              <td align="left">
                <italic>Moriyama et al., 2003</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Chloraminophen (Chlorambucil)</td>
              <td align="left">Reduction in creatinine levels, disappearance of proteinuria and haematuria</td>
              <td align="left">
                <italic>Nabarra et al., 2003</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Mycophenolate mofetil</td>
              <td align="left">Continued rapid deterioration in renal function</td>
              <td align="left">
                <italic>Ovuworie et al., 2000</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone, Cyclophosphamide, plasmapheresis &amp; immunoglobulins</td>
              <td align="left">Fibrils in renal transplant patient, continued rapid deterioration in renal function</td>
              <td align="left">
                <italic>Palanichamy et al., 1998</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Various combinations of Cyclosporin A</td>
              <td align="left">Biopsy proven recurrence of fibrillary glomerulopathy in 3 transplanted kidneys</td>
              <td align="left">
                <italic>Pronovost et al., 1996</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone, Azathioprine and ATG (in 1 patient)</td>
              <td align="left">Rate of decline in renal allografts slower than native kidneys suggesting either benefit of immunosuppressive therapy or spontaneous remission with time</td>
              <td/>
            </tr>
            <tr>
              <td align="left">20 treated patients out of 56</td>
              <td align="left">No effect of immunosuppression on incidence of or time to end stage renal disease</td>
              <td align="left">
                <italic>Rosenstock et al., 2003</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Steroids alone (16% of patients)</td>
              <td align="left">Variable response including improvement in renal function and reduction in proteinuria</td>
              <td/>
            </tr>
            <tr>
              <td align="left">Cyclophosphamide +/- steroids (14%)<break/>Cyclosporin (5%)</td>
              <td align="left">Poor response of patients with immunotactoid glomerulopathy to immunosuppression except one good responder to fludarabine with improvement in renal function and reduced proteinuria</td>
              <td/>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Cyclophosphamide</td>
              <td align="left">Recovery of renal function, discontinuation of dialysis, recovery from pulmonary haemorrhage</td>
              <td align="left">
                <italic>Rovin et al., 1993</italic>
              </td>
            </tr>
            <tr>
              <td align="left">Prednisolone &amp; Chlorambucil</td>
              <td align="left">Reduction or stabilization in creatinine levels, reduction in proteinuria</td>
              <td align="left">
                <italic>Schneider et al., 1996</italic>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>This case highlights the need for routine electron microscopy in native renal biopsies, where the differential diagnosis is wide and varied and the light and immunofluorescence microscopic findings may be non specific.</p>
      <p>The diagnosis of FibGN cannot be made on the basis of the size of the fibrils alone. A therapeutic trial of cyclophosphamide and prednisolone in patients with progressive renal dysfunction who are able to tolerate the treatment, and who understand the risks is worthwhile. This may prevent or slow down the progression of renal failure.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>MMJ was involved in drafting and revising the original manuscript. HD reported the renal biopsy findings and was involved in revising the manuscript. ST was the consultant responsible for the management of this patient. He was involved in critically revising the manuscript. All the authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2369/8/7/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We thank Dr. Alan Curry, Consultant Clinical Scientist for the Electron micrographs. Written consent was obtained from the patient for publication of their medical history.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulopathy</article-title>
          <source>Kid Int</source>
          <year>1998</year>
          <volume>53</volume>
          <fpage>1421</fpage>
          <lpage>1429</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1523-1755.1998.t01-1-00094.x</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eliakim</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Nephrotic Syndrome associated with amyloid like deposits</article-title>
          <source>Nephron</source>
          <year>1977</year>
          <volume>18</volume>
          <fpage>301</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">865657</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alpers</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Hopper</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Biava</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features</article-title>
          <source>Kid Int</source>
          <year>1987</year>
          <volume>31</volume>
          <fpage>781</fpage>
          <lpage>789</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adey</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>MacPherson</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Groggel</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Glomerulonephritis with associated hypocomplementemia and crescents: an unusual case of fibrillary glomerulonephritis</article-title>
          <source>J Am Soc Nephrol</source>
          <year>1995</year>
          <volume>6</volume>
          <fpage>171</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">7579081</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fogo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Qureshi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Morphological and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy</article-title>
          <source>Am J Kidney Dis</source>
          <year>1993</year>
          <volume>22</volume>
          <fpage>367</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">8372831</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivanyi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Degrell</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis and immunotactoid glomerulopathy</article-title>
          <source>Nephro Dial Transplantat</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>2166</fpage>
          <lpage>2170</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfh376</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ronco</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aucouturier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moulin</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Johnson RJ, Feehally J</surname>
            </name>
          </person-group>
          <article-title>Renal amyloidosis and glomerular disease with monoclonal immunoglobulin deposit</article-title>
          <source>Comprehensive Clinical Nephrology</source>
          <year>2003</year>
          <edition>2</edition>
          <publisher-name>Spain, Elsevier Science</publisher-name>
          <fpage>398</fpage>
          <lpage>400</lpage>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenstock</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Markowitz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Valeri</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Sacchi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Appel</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>D'Agati</surname>
              <given-names>VD</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathological features</article-title>
          <source>Kidney Int</source>
          <year>2003</year>
          <volume>63</volume>
          <fpage>1450</fpage>
          <lpage>1461</lpage>
          <pub-id pub-id-type="pmid">12631361</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00853.x</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Korbet</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Immunotactoid glomerulopathy</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1390</fpage>
          <lpage>1397</lpage>
          <pub-id pub-id-type="pmid">11961029</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000013397.06964.19</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guerra</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Narayan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Jaber</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection</article-title>
          <source>Clin Nephrol</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>364</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">14640243</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iskandar</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Jennette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Clinical and pathologic features of fibrillary glomerulonephritis</article-title>
          <source>Kidney Int</source>
          <year>1992</year>
          <volume>42</volume>
          <fpage>1401</fpage>
          <lpage>1407</lpage>
          <pub-id pub-id-type="pmid">1474772</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hvala</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferluga</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vizjak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koselj-Kajtna</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary noncongophilic renal and extrarenal deposits: a report of 10 cases</article-title>
          <source>Ultrastruct Pathol</source>
          <year>2003</year>
          <volume>27</volume>
          <fpage>341</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">14708725</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glenner</surname>
              <given-names>GG</given-names>
            </name>
          </person-group>
          <article-title>Amyloid deposits and amylodosis. The beta fibrilloses</article-title>
          <source>N Eng J Med</source>
          <year>1980</year>
          <volume>302</volume>
          <fpage>1283</fpage>
          <lpage>1292</lpage>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masson</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary hemorrhage in a patient with fibrillary glomerulonephritis</article-title>
          <source>N Eng J Med</source>
          <year>1992</year>
          <volume>326</volume>
          <fpage>36</fpage>
          <lpage>39</lpage>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis</article-title>
          <source>Chin Med J (Tapei)</source>
          <year>2001</year>
          <volume>64</volume>
          <fpage>419</fpage>
          <lpage>452</lpage>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blume</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ivens</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Helmchen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jehle</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Grabensee</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge</article-title>
          <source>Am J Kid Dis</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>420</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="pmid">12148119</pub-id>
          <pub-id pub-id-type="doi">10.1053/ajkd.2002.34548</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rovin</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Bou-Khalil</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sedmak</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary renal syndrome in a patient with fibrillary glomerulonephritis</article-title>
          <source>Am J Kid Dis</source>
          <year>1993</year>
          <volume>22</volume>
          <fpage>713</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="pmid">8238018</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asaba</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tojo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lika</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mimura</surname>
              <given-names>ON</given-names>
            </name>
            <name>
              <surname>Kido</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis associated with essential thrombocytosis</article-title>
          <source>Clin Exp Nephrol</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>296</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">14712360</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10157-003-0250-2</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bijol</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Agrawal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Abernethy</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Rifkin</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Nos&#xE9;</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>A 57-Year-Old Woman With Recently Diagnosed SLE, Proteinuria, and Microhematuria</article-title>
          <source>Am J Kid Dis</source>
          <year>2006</year>
          <volume>48</volume>
          <fpage>1004</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">17162159</pub-id>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2006.09.012</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bircan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Toprak</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kilicalslan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Solakoglu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Uysal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ponard</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Turker</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Factor H deficiency and fibrillary glomerulopathy</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>727</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="pmid">14767033</pub-id>
          <pub-id pub-id-type="doi">10.1093/ndt/gfg605</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bridoux</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hugue</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Coldefy</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Goujon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bauwens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sechet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Preud'homme</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Touchard</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunological features</article-title>
          <source>Kidney Int</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>1764</fpage>
          <lpage>1775</lpage>
          <pub-id pub-id-type="pmid">12371978</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00628.x</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis in siblings</article-title>
          <source>Am J Kid Dis</source>
          <year>1998</year>
          <volume>31</volume>
          <fpage>E4</fpage>
          <pub-id pub-id-type="pmid">10074581</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dickenmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schaub</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nickeleit</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mihatsch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steiger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness</article-title>
          <source>Am J Kid Dis</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>E9</fpage>
          <pub-id pub-id-type="pmid">12200826</pub-id>
          <pub-id pub-id-type="doi">10.1053/ajkd.2002.34933</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dussol</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kaplanski</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Brunet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pellissier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Berland</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>2630</fpage>
          <lpage>2632</lpage>
          <pub-id pub-id-type="pmid">9794573</pub-id>
          <pub-id pub-id-type="doi">10.1093/ndt/13.10.2630</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gielen</surname>
              <given-names>GAL</given-names>
            </name>
            <name>
              <surname>Wetzels</surname>
              <given-names>JFM</given-names>
            </name>
            <name>
              <surname>Steenbergen</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Muddle</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis in a patient with type 2 diabetes mellitus</article-title>
          <source>Neth J Med</source>
          <year>2006</year>
          <volume>64</volume>
          <fpage>119</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">16609159</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahajan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kalra</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dinda</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Tiwari</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Bhowmik</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dash</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis presenting as rapidly progressive renal failure in a young female: a case report</article-title>
          <source>Int Uro Nephrol</source>
          <year>2005</year>
          <volume>37</volume>
          <fpage>561</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1007/s11255-004-4707-3</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moriyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsukada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nitta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Horita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yumura</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nihei</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A case of immunotactoid glomerulopathy with IgA2, &#x3BA; deposition ameliorated by steroid therapy</article-title>
          <source>Nippon Jinzo Gakkai Shi</source>
          <year>2003</year>
          <volume>45</volume>
          <fpage>449</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">14509221</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nabarra</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Larquet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Diemert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leblond</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Baumelou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beaufils</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Unusual IgM fibrillar deposits in glomerulonephritis: Ultrastructural and diffraction studies in a case report</article-title>
          <source>Hum Pathol</source>
          <year>2003</year>
          <volume>34</volume>
          <fpage>1350</fpage>
          <lpage>1354</lpage>
          <pub-id pub-id-type="pmid">14691923</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2003.07.007</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ovuworie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Volmar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Charney</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kravet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Racusen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Rapidly progressive renal failure with nephrotic syndrome in a patient with type 2 diabetes mellitus: The differential of fibrillary deposits</article-title>
          <source>Am J Kid Dis</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>173</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">10620562</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palanichamy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Saffarian</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nakhleh</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Provenzano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tayeb</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Fibrillary glomerulonephritis in a renal allograft</article-title>
          <source>Am J Kid Dis</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>E4</fpage>
          <pub-id pub-id-type="pmid">10074592</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pronovost</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Gunning</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Espinoza</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1996</year>
          <volume>11</volume>
          <fpage>837</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="pmid">8671905</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lugassy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schlesinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kopolovic</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yagil</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Fibrillar glomerulopathy associated with chronic lymphocytic leukaemia</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1996</year>
          <volume>11</volume>
          <fpage>1352</fpage>
          <lpage>1355</lpage>
          <pub-id pub-id-type="pmid">8672038</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
